Provided by Tiger Trade Technology Pte. Ltd.

ETF & Stock Investment

2,069.00
-27.8210-1.33%
Number of Gainers:353
Number of Losers:657
Number of Flat:11
PE:- -
High:2,096.83
Open:2,096.83
Low:2,066.85
Close:2,096.82
Volume:3.95B
Turnover:498.66B
Market Cap:96.21T
Float Cap:90.11T

Loading ...

German Rapeseed Cash Prices - Oct. 8

Dow Jones
·
Oct 08

Marimaca Copper Names Peter Garner-Winship as Finance Chief

Dow Jones
·
Oct 08

Marimaca Copper Names New CFO as Chilean Flagship Project Advances

TIPRANKS
·
Oct 08

Morocco Aerospace Exports Could Rise to $5 Billion, Industry Group Says

Reuters
·
Oct 08

3 Stocks That May Be Undervalued By Up To 47.8%

Simply Wall St.
·
Oct 08

Silver's long-term outlook remains bullish as new investment products offer income opportunities - Amplify ETFs

Kitco
·
Oct 08

Gartner Price Target Raised to $182.00/Share from $177.00 by Morgan Stanley

Dow Jones
·
Oct 08

Bristol Myers’ zenbexus in combination shows efficacy in Phase 3 myeloma trial

TIPRANKS
·
Oct 08

Westinghouse Air Brake Technologies (WAB) Receives a Hold from Wells Fargo

TIPRANKS
·
Oct 08

Veeva Hosts R&D and Quality Summit Spotlighting AI Innovations in Biopharma Operations

Reuters
·
Oct 08

JPMorgan Trims Stake in Anker Innovations (00668) by About 43,700 Shares at Roughly HK$113.65 Each

Stock News
·
Oct 08

Why Nvidia and AMD Stocks Are Edging Lower Today (October 8) — and What Analysts Expect Next

TIPRANKS
·
Oct 08

Gogo Signs USD 15 Million-Plus GEO Satellite Connectivity Lease with Overseas Sovereign Customer

Reuters
·
Oct 08

Alternative Ballistics Launches Direct-to-Consumer E-Commerce Platform for Home Defense Product

Reuters
·
Oct 08

Auddia Posts CEO Letter Updating on Proposed Merger with Thramann Holdings

Reuters
·
Oct 08

Gilat DataPath Wins over $8 Million in U.S. Department of War Satcom Support Orders

Reuters
·
Oct 08

Akamai to Host Investor Call on Third-Quarter 2026 Results

Reuters
·
Oct 08

Aclarion Broadens Clarity Trial Enrollment Criteria to Speed Recruitment, Readout Timing Under Review

Reuters
·
Oct 08

Lexeo Therapeutics to Join Fireside Chat at Chardan Healthcare Conference

Reuters
·
Oct 08

Editas Wins Australian Clearance to Start Phase 1/2 EDIT-401 Trial in HeFH Patients

Reuters
·
Oct 08